Evidence map›Paper›PMID 24302123›Full record

ArticleChemical communications (Cambridge, England)2014

Discovery of new G-quadruplex binding chemotypes.

Stephan A Ohnmacht, Ehsan Varavipour, Rupesh Nanjunda, Ingrida Pazitna, Gloria Di Vita, Mekala Gunaratnam, Arvind Kumar, Mohamed A Ismail, David W Boykin, W David Wilson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Stephan A OhnmachtSchool of Pharmacy, University College London, London WC1N 1AX, UK. s.neidle@ucl.ac.uk.
Ehsan Varavipour
Rupesh Nanjunda
Ingrida Pazitna
Gloria Di Vita
Mekala Gunaratnam
Arvind Kumar
Mohamed A Ismail
David W Boykin
W David Wilson
Stephen Neidle
University College London · GBCenter for Drug Evaluation and Research · USGeorgia State University · USAID Atlanta · US

Funding

Heterocycle Cation Recognition of the DNA Minor Groove.R01AI064200 · NIAID · GEORGIA STATE UNIVERSITY · PI WILSON, W DAVID · 2005 to 2014
$3.4M
Medical Research CouncilNIAID NIH HHS AI-064200NIAID NIH HHS R01 AI064200
6 · The paper itself

Abstract

We report here on the discovery and preliminary evaluation of a novel non-macrocyclic low molecular weight quadruplex-stabilizing chemotype. The lead compounds, based on a furan core, show high G-quadruplex stabilisation and selectivity as well as potent in vitro anti-proliferative activity.

Indexed as

G-QuadruplexesAntineoplastic AgentsCell Line, TumorCell SurvivalCircular DichroismFuransHumansAntineoplastic AgentsfuranFurans

Identifiers

PMID24302123
PMCPMC3901018
OpenAlexW2092797585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.